Clinical Trial Detail

NCT ID NCT03404726
Title A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

myelodysplastic syndrome

chronic myelomonocytic leukemia

acute myeloid leukemia

Therapies

BAY2402234

Age Groups: adult senior

No variant requirements are available.